Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAM2029 in Acromegaly
NCT04076462Phase 3Completed
- Sponsor
- Camurus
- Start
- Aug 2019
- Primary completion
- May 2023
- Modality
- Peptides
- Countries
- 10
01
Overview
A Phase 3 trial of octreotide hydrochloride in acromegaly, sponsored by Camurus. Started Aug 2019; status: completed.
02
Drugs
octreotide hydrochloride
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT04076462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04076462.